Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
ADHDBipolar Disorder
Interventions
DRUG

methylphenidate HCl (Concerta)

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00181987 - Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder | Biotech Hunter | Biotech Hunter